Cardiac norepinephrine release: modulation by ovariectomy and estrogen.
Previously, we have demonstrated that in contrast to male rats, female rats do not show an age-related reduction of depolarization-elicited norepinephrine (NE) release from cardiac synaptosomes (resealed nerve terminals). These results suggest that sex hormones such as estrogen may modulate NE release from cardiac synaptosomes prepared from female rats. The present study was designed to test the hypotheses that long-term estrogen depletion, resulting from ovariectomy, and estrogen replacement alters depolarization-elicited NE release from cardiac synaptosomes. Female F344 rats were divided into two groups, one of which underwent bilateral ovariectomy, whereas the other underwent a sham operation. Three ovariectomized subgroups received daily injections of conjugated equine estrogens, delta8,9-dehydroestrone or 17 alpha-dihydroequilenin. Another ovariectomized control subgroup and the sham-operated animals received daily injections of vehicle. After 90 or 270 days of treatment, the animals were sacrificed. Cardiac synaptosomes were prepared from each heart, incubated with [(3)H]-NE, and used to evaluate NE release capacity by exposure to 50 mM K(+). The effectiveness of the ovariectomy and the estrogenic actions of the test compounds was confirmed by evaluating vaginal smears, determining uterine weights, and measuring serum luteinizing hormone (LH) concentrations. Ovariectomy (after both 90 and 270 days) significantly increased depolarization-induced NE release compared with sham-operated rats. Treatment with all three estrogenic preparations reduced NE release in ovariectomized rats to values similar to those observed in sham-operated animals. Interestingly, NE release rates from rats treated with conjugated estrogens for 270 but not 90 days were significantly below that observed in age-matched sham animals. These results demonstrate that estrogen modulates depolarization-elicited NE release from cardiac nerve terminals. Such modulation may represent a protective action by estrogen at the cardiac synapse.
Eskin
Bernard A
BA
Department of Obstetrics, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, USA. bae22@drexel.edu
Snyder
David L
DL
Roberts
Jay
J
Aloyo
Vincent J
VJ
D000316:Adrenergic alpha-Agonists / Q000378:metabolism*; D000818:Animals; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D008297:Male; D008564:Membrane Potentials; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D009929:Organ Size; D010052:Ovariectomy; D011869:Radioligand Assay; D011897:Random Allocation; D051381:Rats; D011916:Rats, Inbred F344; D013574:Synaptosomes / Q000378:metabolism; D014599:Uterus / Q000033:anatomy & histology
D000316:Adrenergic alpha-Agonists; D004967:Estrogens; D009638:Norepinephrine